| Glucose input regime |
Glucose-limited to glucose pulse (0.25 g L | −1 | ATP surplus can cause the observed overactivation of initial glycolytic steps in DTps1 mutant strains. |
In vivo behavior cannot be predicted with in vitro kinetics. |
Implementation of allosteric regulation and in vivo measured parameter values is necessary to reproduce GP data. |
| ) |
Glucose-limited to glucose pulse (1 g L | −1 | ) |
Glucose-limited to glucose pulse (1 g L | −1 | ) |
Glucose-limited to glucose pulse (1 g L | −1 | ) |
GLYCO |
Individual + branch reactions (++) |
Lumped reactions (+) |
Individual + branch reactions (++) |
| Experimental setup |
30 °C, pH5, aerobic, D = 0.1 h | Individual + branch reactions (++) |
| −1 | , STR, direct sampling |
30 °C, pH5, aerobic, D = 0.1 h | −1 | , STR, direct sampling |
30 °C, pH5, aerobic, D = 0.1 h | −1 | , STR, direct sampling |
30 °C, pH5, aerobic, D = 0.05 h | −1 | , STR, BioScope sampling |
TRE |
N/A |
| Duration | N/A |
N/A |
T6P regulation (+) |
| 500 s |
180 s |
180 s |
80 s |
TCA |
Individual reactions (++) |
N/A |
N/A |
N/A |
| Strain |
CBS 7336 (ATCC 32167) |
CBS 7336 (ATCC 32167) |
CBS 7336 (ATCC 32167) |
CEN.PK113-7D |
PPP |
N/A |
N/A |
N/A |
N/A |
| Measurement technique |
Enzymatic assay |
Enzymatic assay: metabolites, NAD(H) HPLC: adenine nucleotides |
Enzymatic assay: metabolites, NAD(H) |
Enzymatic assay: ATP, NADX and G6P MS: glycolytic intermediates |
Cofactors |
Conservation moiety (+) |
Conservation moiety (+) |
| Intracellular variables measured | Conservation moiety (+) |
GLYCO | : G6P. | Conservation moiety (+) |
| GLYCO | : G6P, F6P, FBP, GAP, 3PG, PEP, PYR. | NUC | : NAD(H), AXP (whole cell and cytoplasmic). Pi. |
GLYCO | : G6P, F6P. PPP: 6PG. | NUC | : NADP(H). |
GLYCO | : G6P, F6P, G1P, FBP, 2GP+3PG, PEP, PYR. | NUC | : ATP, NADX. |
Parameters |
Computational, in vivo (++) |
Computational, toy model (+) |
Computational, in vivo (++) |
Experimental and computational, in vivo (++) |
| Glucose input regime |
Glucose-limited to glucose pulse (1 g L | −1 | ) |
Glucose-limited to glucose pulse (1 g L | −1 | ) |
Glucose-limited to glucose pulse (1 g L | −1 | ) |
Trehalose-limited to glucose pulse (20 g L | −1 | ) |
Data |
Single GP experiment (++) |
Single GP, toy data (+) |
| Experimental setup |
30 °C, pH5, aerobic, D = 0.05 h | −1 | , STR, BioScope sampling |
30 °C, pH5, aerobic, D = 0.05 h | −1 | , STR, BioScope samplingSS data point (+) |
30 °C, pH5, aerobic, D = 0.05 hSingle GP experiment and multiple SS (+++) |
| −1 | , STR, direct sampling |
30 °C, pH4.8, aerobic, SF, direct sampling. |
|
Smallbone et al. [16] |
Van Heerden et al. [18] |
Messiha et al. [33] |
Kesten et al. [20] |
| Duration |
180 s |
180 s |
300 s |
30 min |
Contribution to glycolytic understanding |
Broad quantification of enzymatic kinetic constants in in vivo-like conditions. |
Glycolytic dynamics combined with cell heterogeneity determine cell fate. |
Feasibility of constructing larges network models by merging smaller pathway models. |
Cooperativity PYK-PYR and ADH-PDH bypass play a major role in the onset of the Crabtree effect. |
| Strain |
CEN.PK113-7D |
CEN.PK113-7D |
CEN.PK113-7D |
BY4741 |
GLYCO |
Individual + branch reactions + isozymes (+++) |
Individual + branch reactions (++) |
Individual + branch reactions (++) |
Individual + branch reactions (++) |
| Measurement technique |
MS |
Enzymatic analysis: NAD(H) MS |
MS |
MS |
TRE |
N/A |
T6P regulation (+) |
N/A |
N/A |
| Intracellular variables measured |
GLYCO | : G6P, F6P, FBP, 2/3PG, PEP, PYR. | TCA | : ISOCIT, FUM, MAL, AKG, SUC. | PPP | : 6PG. | TRE | : G1P, T6P, TRE. | NUC | : AXP, NADH:NAD ratio. |
GLYCO | : G6P, F6P, F1,6P2, F2,6P2, 2/3PG, PEP. | TCA | : ISOCIT, AKG, SUC, FUM, MAL. | PPP | : 6PG. | TRE | : G1P, T6P. | NUC | : AXP, NADH:NAD ratio. |
GLYCO | : G6P, F6P, F1,6P2, F2,6P2, 2/3PG, PEP. | TCA | : ISOCIT, AKG, SUC, FUM, MAL. | PPP | : 6PG. | TRE | : G1P, T6P. | NUC | : AXP, NADH:NAD ratio. AAs. |
GLYCO | : G6P, F6P, FBP, G3P, 2/3PG, PEP. | TCA | : AKG, MAL. | PPP | : 6PG, R5P, R1P. | TRE | : T6P, G1P. | NUC | : ATP, ADP, AMP, IMP, INO, HYP, GTP, GDP, GMP. |
TCA |
N/A |
N/A |
| |
Van Heerden et al. [18] | N/A |
Suarez-Mendez et al. [ | Individual reactions (++) |
| 36 | ], Suarez-Mendez et al. [ | 37] |
Canelas et al. [34] |
Kumar et al. [35] |
PPP |
N/A |
N/A |
Individual reactions (++) |
N/A |
| Cofactors |
Conservation moiety (+) |
Conservation moiety + dynamic Pi (++) |
Conservation moiety (+) |
Conservation moiety (+) |
| Parameters |
Experimental, in vivo (++) |
Experimental, in vivo (++) |
Experimental, in vivo (++) |
Computational, in vivo (++) |
| Data |
N/A |
Single GP experiment (++) |
Single GP experiment (++) |
Single GP experiment (++) |